Roche outlines developmental investment plans for Basel site

23 October 2014 (Last Updated October 23rd, 2014 18:30)

Swiss healthcare company Roche has announced plans to invest CHF3bn ($3.14bn) in the construction of modern research infrastructure, attractive workplaces and sustainable site development at its Basel site over the next ten years.

Roche site

Swiss healthcare company Roche has announced plans to invest CHF3bn ($3.14bn) in the construction of modern research infrastructure, attractive workplaces and sustainable site development at its Basel site over the next ten years.

Developed in collaboration with architectural firm Herzog & de Meuron, the development plan will see the company spending CHF1.7bn ($1.78bn) on a new research centre comprising four integrated office / laboratory buildings for 1,900 employees at its Building 74.

With heights measuring 132m, 72m, 28m and 16m, the new buildings will contain 950 office and 950 laboratory workplaces that meet requirements of scientists, and are scheduled to enter into service between 2021 and 2022.

In addition, an in-vivo research facility would be constructed on the site of Building 61 on Wettsteinallee, by the end of 2018, which will address the current standards for experimental animal care.

Roche CEO Severin Schwan said: "Roche is committed long-term to Switzerland and to Basel in its dual role as corporate headquarters and one of our most important sites worldwide.

"Employees from all parts of the company are making a vital contribution to Roche's innovative strength and we want to provide them with an attractive work environment."

"Roche also plans to renovate the historic Building 21 from 2016, to bring it into line with modern energy-efficiency standards and building infrastructure requirements." 

Roche Basel / Kaiseraugst site head Jürg Erismann said: "The planned consolidation of the existing industrial site will eliminate the need to build over green zones.

"Instead, Roche will be making more efficient use of those parts of the site that have already been developed but cannot be expanded."

The company is spending CHF550m ($576m) on construction of a 205m tall building in the interior of the Roche site by 2021, which will provide space for up to 1,700 office workplaces.

Around CHF700m ($733m) is being spent on upgrading existing buildings and in infrastructure, including a logistics centre, alongside relocation of workshop, fire service, medical service and local site into the new buildings.

The underground car park beneath Building 74 is to be replaced by a car park of identical capacity, but 1,500 new underground bicycle parking stands will be added.

Roche also plans to renovate the historic Building 21 from 2016, to bring it into line with modern energy-efficiency standards and building infrastructure requirements at an estimated cost of CHF85m ($89m).

Herzog & de Meuron said: "With the Roche area development plan, we see a basic principle of our work realised and that is densification.

"This is relevant for the entirety of Basel, even for all of Switzerland, as well as for the current national discourse regarding urban sprawl."


Image: Roche is investing $3.14bn on construction of modern research infrastructure at its Basel site over the next ten years. Photo: © 2014 F. Hoffmann-La Roche Ltd.